PriceTargets.com logo

OTCMKTS:PETV - PetVivo Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $7.00
  • Forecasted Upside: 215.32 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.22 As of 08/11/2022 01:00 AM ET
▼ -0.03 (-1.33%)

This chart shows the closing price for PETV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New PetVivo Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PETV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PETV

Analyst Price Target is $7.00
▲ +215.32% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for PetVivo in the last 3 months. The average price target is $7.00, with a high forecast of $7.00 and a low forecast of $7.00. The average price target represents a 215.32% upside from the last price of $2.22.

This chart shows the closing price for PETV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in PetVivo.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/17/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/18/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/16/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/14/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/12/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/13/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/12/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/11/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/11/2021ThinkEquityInitiated CoverageBuy$7.00
(Data available from 8/12/2017 forward)

News Sentiment Rating

0.52 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/13/2022
  • 4 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/12/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/14/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/13/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/13/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/12/2022
  • 4 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/12/2022
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/11/2022

Current Sentiment

  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

PetVivo logo
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
Read More

Today's Range

Now: $2.22
Low: $2.20
High: $2.25

50 Day Range

MA: $1.99
Low: $1.58
High: $2.63

52 Week Range

Now: $2.22
Low: $1.20
High: $5.14

Volume

19,714 shs

Average Volume

108,542 shs

Market Capitalization

$22.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.96

Frequently Asked Questions

What sell-side analysts currently cover shares of PetVivo?

The following sell-side analysts have issued stock ratings on PetVivo in the last year: ThinkEquity.
View the latest analyst ratings for PETV.

What is the current price target for PetVivo?

1 Wall Street analysts have set twelve-month price targets for PetVivo in the last year. Their average twelve-month price target is $7.00, suggesting a possible upside of 215.3%. ThinkEquity has the highest price target set, predicting PETV will reach $7.00 in the next twelve months. ThinkEquity has the lowest price target set, forecasting a price of $7.00 for PetVivo in the next year.
View the latest price targets for PETV.

What is the current consensus analyst rating for PetVivo?

PetVivo currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PETV will outperform the market and that investors should add to their positions of PetVivo.
View the latest ratings for PETV.

What other companies compete with PetVivo?

Other companies that are similar to PetVivo include Aethlon Medical, Bluejay Diagnostics, Femasys, Neovasc and NeuroMetrix. Learn More about companies similar to PetVivo.

How do I contact PetVivo's investor relations team?

PetVivo's physical mailing address is 5251 EDINA INDUSTRIAL BLVD, EDINA MN, 55439. The company's listed phone number is (952) 405-6216 and its investor relations email address is [email protected] The official website for PetVivo is www.petvivo.com. Learn More about contacing PetVivo investor relations.